Regardless of the study arm a patient is assigned, study treatment will continue for a maximum of 24 weeks (8 cycles) from the cycle 1 day 1 date. For patients on BCG-containing arms, standard of care maintenance BCG treatment according to the SWOG 8507 schedule will continue for a maximum of 36 months.